rel-Methyl (1R,3S,4R)-4-((tert-butoxycarbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)cyclohexane-1-carboxylate

Catalog No. :
ACMACR421
CAS No. :
874824-37-0
Molecular Formula :
C19H37NO5Si
Molecular Weight :
387.59

IUPAC Name:methyl (1R,3S,4R)-4-((tert-butoxycarbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)cyclohexane-1-carboxylate

rel-Methyl (1R,3S,4R)-4-((tert-butoxycarbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)cyclohexane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-Methyl (1R,3S,4R)-4-((tert-butoxycarbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)cyclohexane-1-carboxylate
IUPAC Namemethyl (1R,3S,4R)-4-((tert-butoxycarbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)cyclohexane-1-carboxylate
Molecular FormulaC19H37NO5Si
Molecular Weight387.59
SMILESO=C(OC)[C@H]1C[C@@H]([C@@H](CC1)NC(OC(C)(C)C)=O)O[Si](C(C)(C)C)(C)C
InChI KeyBKZOIQZVMBXKNE-KFWWJZLASA-N
Synonymrel-Methyl (1R,3S,4R)-4-((tert-butoxycarbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)cyclohexane-1-carboxylate;Cyclohexanecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, methyl ester, (1R,3S,4R)-rel-
CAS No.874824-37-0

Synthetic Route by SureRoute

1. ACMACR421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMACR421 route product structure diagram
    ACMACR421874824-37-0
Inquiry

2. ACMACR421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMACR421 route product structure diagram
    ACMACR421874824-37-0
Inquiry

Comments (0)